[CAP7 (1-16)]2, (sC18)2
General Information
DRACP ID DRACP03734
Peptide Name [CAP7 (1-16)]2, (sC18)2
Sequence GLRKRLRKFRNKIKEK,GLRKRLRKFRNKIKEK
Sequence Length 33
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral Mix
Physicochemical Information
Formula C184H332N68O38
Absent amino acids ACDHMPQSTVWY
Common amino acids K
Mass 467602
Pl 12.75
Basic residues 18
Acidic residues 2
Hydrophobic residues 8
Net charge 16
Boman Index -16440
Hydrophobicity -181.82
Aliphatic Index 70.91
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 23209513
Title Dimerization of a cell-penetrating peptide leads to enhanced cellular uptake and drug delivery
Doi Not available
Year 2012
Literature 2
Pubmed ID 27860402
Title Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity
Doi Not available
Year 2017
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 12024